246 related articles for article (PubMed ID: 8823291)
1. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.
Sinha MK; Opentanova I; Ohannesian JP; Kolaczynski JW; Heiman ML; Hale J; Becker GW; Bowsher RR; Stephens TW; Caro JF
J Clin Invest; 1996 Sep; 98(6):1277-82. PubMed ID: 8823291
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of leptin.
Sinha MK; Caro JF
Vitam Horm; 1998; 54():1-30. PubMed ID: 9529971
[TBL] [Abstract][Full Text] [Related]
3. Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans.
Ogier V; Ziegler O; Méjean L; Nicolas JP; Stricker-Krongrad A
Int J Obes Relat Metab Disord; 2002 Apr; 26(4):496-503. PubMed ID: 12075576
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term fasting on free and bound leptin concentrations in lean and obese women.
Landt M; Horowitz JF; Coppack SW; Klein S
J Clin Endocrinol Metab; 2001 Aug; 86(8):3768-71. PubMed ID: 11502809
[TBL] [Abstract][Full Text] [Related]
5. Secretion of free and protein-bound leptin from subcutaneous adipose tissue of lean and obese women.
Brabant G; Nave H; Mayr B; Behrend M; van Harmelen V; Arner P
J Clin Endocrinol Metab; 2002 Aug; 87(8):3966-70. PubMed ID: 12161541
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation.
Hoggard N; Johnstone AM; Faber P; Gibney ER; Elia M; Lobley G; Rayner V; Horgan G; Hunter L; Bashir S; Stubbs RJ
Clin Endocrinol (Oxf); 2004 Jul; 61(1):31-9. PubMed ID: 15212642
[TBL] [Abstract][Full Text] [Related]
7. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity.
Korbonits M; Trainer PJ; Little JA; Edwards R; Kopelman PG; Besser GM; Svec F; Grossman AB
Clin Endocrinol (Oxf); 1997 Jun; 46(6):751-7. PubMed ID: 9274707
[TBL] [Abstract][Full Text] [Related]
8. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans.
Clapham JC; Smith SA; Moore GB; Hughes MG; Azam H; Scott A; Jung RT
Int J Obes Relat Metab Disord; 1997 Mar; 21(3):179-83. PubMed ID: 9080255
[TBL] [Abstract][Full Text] [Related]
9. The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks.
Campfield LA; Smith FJ; Burn P
Horm Metab Res; 1996 Dec; 28(12):619-32. PubMed ID: 9013731
[TBL] [Abstract][Full Text] [Related]
10. Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats.
Korner J; Wardlaw SL; Liu SM; Conwell IM; Leibel RL; Chua SC
Endocrinology; 2000 Jul; 141(7):2465-71. PubMed ID: 10875247
[TBL] [Abstract][Full Text] [Related]
11. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.
Korner J; Savontaus E; Chua SC; Leibel RL; Wardlaw SL
J Neuroendocrinol; 2001 Nov; 13(11):959-66. PubMed ID: 11737554
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
Chan JL; Wong SL; Mantzoros CS
Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
[TBL] [Abstract][Full Text] [Related]
13. [Leptin].
Nedvídková J
Cesk Fysiol; 1997 Dec; 46(4):182-8. PubMed ID: 9601742
[TBL] [Abstract][Full Text] [Related]
14. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.
Igel M; Becker W; Herberg L; Joost HG
Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of a putative high affinity human soluble leptin receptor.
Liu C; Liu XJ; Barry G; Ling N; Maki RA; De Souza EB
Endocrinology; 1997 Aug; 138(8):3548-54. PubMed ID: 9231810
[TBL] [Abstract][Full Text] [Related]
16. Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay.
Wu Z; Bidlingmaier M; Liu C; De Souza EB; Tschöp M; Morrison KM; Strasburger CJ
J Clin Endocrinol Metab; 2002 Jun; 87(6):2931-9. PubMed ID: 12050276
[TBL] [Abstract][Full Text] [Related]
17. Localization of leptin receptor immunoreactivity in the lean and obese Zucker rat brain.
Yarnell DO; Knight DS; Hamilton K; Tulp O; Tso P
Brain Res; 1998 Feb; 785(1):80-90. PubMed ID: 9526052
[TBL] [Abstract][Full Text] [Related]
18. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.
Yannakoulia M; Yiannakouris N; Blüher S; Matalas AL; Klimis-Zacas D; Mantzoros CS
J Clin Endocrinol Metab; 2003 Apr; 88(4):1730-6. PubMed ID: 12679465
[TBL] [Abstract][Full Text] [Related]
19. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.
Caro JF; Kolaczynski JW; Nyce MR; Ohannesian JP; Opentanova I; Goldman WH; Lynn RB; Zhang PL; Sinha MK; Considine RV
Lancet; 1996 Jul; 348(9021):159-61. PubMed ID: 8684156
[TBL] [Abstract][Full Text] [Related]
20. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity.
Houseknecht KL; Mantzoros CS; Kuliawat R; Hadro E; Flier JS; Kahn BB
Diabetes; 1996 Nov; 45(11):1638-43. PubMed ID: 8866573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
